Cardiff Oncology Inc Forecast, price target & analysts
Cardiff Oncology Inc Target price 2025 - Analyst rating & recommendation
Cardiff Oncology Inc Classifications & Recommendation:
Cardiff Oncology Inc Price Target
| Target Price | $10.20 |
| Price | $2.05 |
| Potential |
397.56%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Cardiff Oncology Inc 2026 .
The average Cardiff Oncology Inc target price is $10.20.
This is
397.56%
register free of charge
$19.95
873.17%
register free of charge
$3.54
72.44%
register free of charge
|
|
| A rating was issued by 14 analysts: 12 Analysts recommend Cardiff Oncology Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cardiff Oncology Inc stock has an average upside potential 2026 of
397.56%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.68 | 0.44 |
| 38.78% | 34.75% | |
| Net Margin | -6,685.29% | -12,744.55% |
| 21.01% | 90.64% |
10 Analysts have issued a sales forecast Cardiff Oncology Inc 2025 . The average Cardiff Oncology Inc sales estimate is
This results in the following potential growth metrics:
10 Cardiff Oncology Inc Analysts have issued a net profit forecast 2025. The average Cardiff Oncology Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.95 | -0.85 |
| 2.15% | 10.53% | |
| P/E | negative | |
| EV/Sales | 147.44 |
10 Analysts have issued a Cardiff Oncology Inc forecast for earnings per share. The average Cardiff Oncology Inc EPS is
This results in the following potential growth metrics and future valuations:
Cardiff Oncology Inc...
Current Cardiff Oncology Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Jul 08 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Jun 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 09 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Dec 13 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 06 2025 |
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Jul 08 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Jun 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 09 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 28 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Dec 13 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 08 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
